Ortin Global Stock Screener | Share Price & Fundamental Analysis
ORTINGLOBE
Pharmaceuticals
Screen Ortin Global share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹15.41
▼
-0.90 (-5.52%)
Share Price BSE
₹14.39
▲
0.01 (0.07%)
Market Cap
₹11.35 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
9.40
EPS (TTM)
₹-1.04
Dividend Yield
-
Debt to Equity
0.43
52W High
₹16.31
52W Low
₹11.19
Operating Margin
-1617.00%
Profit Margin
-
EBITDA
₹-1.00
Net Income
₹-1.00
Total Assets
₹4.00
Total Equity
₹2.00
Ortin Global Share Price History - Stock Screener Chart
Screen ORTINGLOBE historical share price movements with interactive charts. Analyze price trends and patterns.
Ortin Global Company Profile - Fundamental Screener
Screen Ortin Global company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ORTINGLOBE shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE749B01020
Ortin Global Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ORTINGLOBE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 4 | 7 | 21 | 21 | 21 | 117 | 105 | 74 | 62 | 65 |
| Current Assets | 3 | 6 | 7 | 6 | 6 | 92 | 82 | 52 | 38 | 31 |
| Fixed Assets | 0 | 0 | 14 | 14 | 14 | 23 | 21 | 20 | 21 | 22 |
| Liabilities | ||||||||||
| Total Liabilities | 4 | 7 | 21 | 21 | 21 | 117 | 105 | 74 | 62 | 65 |
| Current Liabilities | 0 | 2 | 3 | 2 | 2 | 9 | 8 | 8 | 8 | 16 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 2 | 3 | 11 | 11 | 11 | 24 | 25 | 24 | 23 | 23 |
| Share Capital | 8 | 8 | 8 | 8 | 8 | 17 | 17 | 17 | 17 | 17 |
| Reserves & Surplus | -6 | -5 | 3 | 3 | 3 | 7 | 8 | 7 | 7 | 6 |
Screen ORTINGLOBE income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 2 | 6 | 8 | 8 | 198 | 168 | 80 | 62 | 64 | 61 |
| Expenses | 1 | 1 | 9 | 6 | 8 | 7 | 192 | 161 | 74 | 56 | 57 | 54 |
| EBITDA | -1 | -1 | -6 | 1 | 1 | 1 | 6 | 7 | 6 | 6 | 7 | 7 |
| Operating Profit % | -1617.00% | -258.00% | -310.00% | 9.00% | 5.00% | 15.00% | 3.00% | 4.00% | 7.00% | 9.00% | 9.00% | 11.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 0 | 0 | 1 | 0 | 1 | 1 | 3 | 3 | 4 | 3 | 3 | 4 |
| Profit Before Tax | -1 | -1 | -7 | 0 | -1 | 0 | 1 | 2 | 1 | 1 | 1 | 1 |
| Tax | 0 | 0 | 1 | 0 | 0 | -1 | 1 | 1 | 0 | 1 | 1 | 0 |
| Net Profit | -1 | -1 | -8 | 0 | 0 | 1 | -1 | 1 | 1 | 1 | 1 | 1 |
| EPS | -1.20 | -1.04 | -9.89 | -0.12 | -0.49 | 1.16 | -0.33 | 0.76 | 0.40 | 0.30 | 0.49 | 0.53 |
Ortin Global Cash Flow Screener - Liquidity Fundamentals
Screen ORTINGLOBE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | -5 | 0 | 2 | 18 | 3 | 7 | 2 | 2 | 1 |
| Investing Activities | 0 | 12 | 0 | 0 | 0 | -3 | -3 | -1 | -1 | -1 |
| Financing Activities | 0 | -4 | 1 | -1 | -10 | -1 | -3 | 0 | -1 | 0 |
| Net Cash Flow | 0 | 4 | 1 | 2 | 8 | -1 | 0 | 1 | 0 | 0 |
Screen ORTINGLOBE shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 1.23% | 21.51% |
| FII Holding | 6.53% | 6.53% | 1.68% | 0.00% | 6.25% | 6.25% | 6.25% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 85.32% | 85.66% | 90.85% | 92.04% | 85.84% | 83.55% | 84.26% | 73.83% |
| Other Holding | 6.92% | 6.58% | 6.23% | 6.73% | 6.68% | 8.97% | 8.26% | 4.66% |
| Shareholder Count | 12,144 | 12,034 | 12,060 | 12,192 | 11,952 | 12,165 | 12,094 | 12,585 |
Ortin Global Dividend Screener - Share Yield Analysis
Screen ORTINGLOBE dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Ortin Global Index Membership - Market Screener Classification
Screen ORTINGLOBE by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Ortin Global Market Events Screener - Corporate Actions
Screen ORTINGLOBE market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -13.38% | ||
| Annual General Meeting | NA | -7.49% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 4.13% |
| 2025-08-25 | 2025-08-25 | Extraordinary General Meeting | NA | -9.94% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -22.74% |
| 2025-05-26 | 2025-05-26 | Quarterly Result Announcement | NA | -1.86% |
| 2025-02-12 | 2025-02-12 | Quarterly Result Announcement | NA | -5.59% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -2.23% |
| 2024-04-11 | 2024-04-11 | Extraordinary General Meeting | NA | 4.57% |
| 2024-04-05 | 2024-04-05 | Extraordinary General Meeting | NA | -3.89% |
| 2024-02-13 | 2024-02-13 | Change Of Name | NA | 0.00% |
| 2023-12-14 | 2023-12-14 | Extraordinary General Meeting | NA | 3.99% |
Ortin Global Competitors Screener - Peer Comparison
Screen ORTINGLOBE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,734 | 39.30 | 54,729 | 9.71% | 10,980 | 39.06 |
| Divis Laboratories | 168,851 | 68.25 | 9,712 | 18.67% | 2,191 | 44.96 |
| Torrent Pharmaceuticals | 129,357 | 59.98 | 11,539 | 6.99% | 1,911 | 59.35 |
| Cipla | 120,557 | 22.21 | 28,410 | 7.12% | 5,291 | 42.76 |
| Dr Reddys Laboratories | 105,645 | 18.46 | 33,741 | 16.73% | 5,725 | 49.97 |
| Lupin | 95,023 | 21.85 | 22,910 | 13.74% | 3,306 | 50.10 |
| Zydus Life Science | 90,707 | 18.09 | 23,511 | 18.55% | 4,615 | 34.06 |
| Mankind Pharma | 88,846 | 50.78 | 12,744 | 20.90% | 2,007 | 40.67 |
| Aurobindo Pharma | 68,901 | 20.36 | 32,346 | 9.43% | 3,484 | 46.33 |
| Alkem Laboratories | 65,390 | 27.28 | 13,458 | 3.70% | 2,216 | 37.45 |
Ortin Global Company Announcements - News Screener
Screen ORTINGLOBE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-03 | Closure of Trading Window | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On 14.11.2025 | View |
| 2025-11-14 | Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2025 | View |
| 2025-11-07 | Board Meeting Intimation for Meeting To Be Held On 14.11.2025 | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-25 | Closure of Trading Window | View |
| 2025-09-08 | Reg. 34 (1) Annual Report. | View |
| 2025-09-08 | Notice Of 38Th AGM Of The Company Scheduled To Be Held On 30.09.2025 | View |
| 2025-09-08 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2025-09-05 | Board Meeting Outcome for Outcome Of Board Meeting Held On | View |
| 2025-08-25 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-08-25 | Shareholder Meeting / Postal Ballot-Outcome of EGM | View |
| 2025-08-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On 14.08.2025 | View |
| 2025-08-14 | Unaudited Financial Results For The Quarter Ended 30.06.2025 | View |
| 2025-08-07 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14-08-2025 | View |
| 2025-08-02 | Notice Of EGM To Be Held On 25.08.2025 | View |
| 2025-08-01 | Clarification On Price Movement With Reference To BSE Email Dated 31.07.2025 | View |